- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04469244
Evaluation of the Use of Radiomics in 18F-FDOPA PET Examinations for the Characterization of Gliomas (RADDOPAG)
August 23, 2022 updated by: Antoine VERGER, Central Hospital, Nancy, France
The evaluation of gliomas in imaging represents a real challenge today, at the initial diagnosis, for therapeutic planning or follow-up treatment of these lesions.
There is an urgent need for non-invasive imaging tools to evaluate a glioma throughout its management.
At present, the diagnosis of certainty is only obtained through an anatomo-pathological analysis with sampling during an invasive procedure (surgery or biopsy).
Magnetic resonance imaging, through perfusion, diffusion imaging or spectroscopy is developing in gliomas.
However, it remains time-consuming and is not always available.
At the same time, positron emission tomography (PET) with amino acids is an interesting alternative for these brain tumours.
Amino acid PET has the advantage of being more specific than the abnormalities detected in MRI and the amino acid radiotracers cross the blood-brain barrier, even if not broken, unlike Gadolinium in MRI.
Among these radiotracers, 18F-FDOPA can, among other things, assist in the non-invasive staging of gliomas at initial diagnosis.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Vandœuvre-lès-Nancy, France, 54511
- CHRU of Nancy
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
common population that underwent a PET/CT scan at 18F-FDOPA for its glioma
Description
Inclusion Criteria:
- Patient having performed a PET/CT examination at 18F-FDOPA for his glioma in the nuclear medicine department of the CHRU de Brabois for which the raw data are available;
- Person who received full information on the organization of the research and did not object to the use of these data;
- Patients affiliated to a social security scheme
Exclusion Criteria:
- - Person who received full information on the organization of the research and who objected to the use of the data
- Adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice).
- A person of full age who is unable to give consent and who is not subject to a legal protection measure.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnostic performance (sensitivity, specificity, accuracy) of parameters extracted from radiomic analysis to predict the molecular characteristics of gliomas at initial diagnosis.
Time Frame: 1 year
|
Evaluating the performance of radiomics use in gliomas at initial diagnosis
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnostic performance (sensitivity, specificity, accuracy) of parameters extracted from radiomic analysis to predict glioma recurrence
Time Frame: 1 year
|
Assessing the performance of radiomics use in the search for glioma recurrence
|
1 year
|
Diagnostic performance (sensitivity, specificity, accuracy) of parameters extracted from radiomic analysis to predict the response to glioma treatments.
Time Frame: 1 year
|
Evaluating the performance of the use of radiomics in the follow-up of glioma disease treatments
|
1 year
|
Comparison of dynamic parameters (time to peak, slope, area under curve) obtained with different reconstruction parameters versus dynamic parameters obtained on digital phantom from literature data
Time Frame: 6 months
|
Optimization of dynamic analysis for the interpretation of the PET/CT examination at 18F-FDOPA
|
6 months
|
Comparison of dynamic parameters (time to peak, slope, area under curve) obtained with different reconstruction parameters versus dynamic parameters obtained on digital phantom from literature data
Time Frame: 1 years
|
Comparison of diagnostic performance of radiomics, static and dynamic parameters.
|
1 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2020
Primary Completion (Actual)
August 3, 2020
Study Completion (Actual)
October 20, 2020
Study Registration Dates
First Submitted
June 25, 2020
First Submitted That Met QC Criteria
July 7, 2020
First Posted (Actual)
July 14, 2020
Study Record Updates
Last Update Posted (Actual)
August 24, 2022
Last Update Submitted That Met QC Criteria
August 23, 2022
Last Verified
December 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020PI063
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Study on the Use of Radiomics in Gliomas of Initial Disgnosis
-
Albert Einstein Healthcare NetworkRobert Wood Johnson FoundationCompletedFocus of the Study is on the Use of Incentives to Promote | Healthier Eating in Low-income CommunitiesUnited States
-
University Hospital of PatrasNot yet recruitingStudy Focuses on the Use of Covered Stents (Stent Grafts) for the Treatment of Dysfunctional Vascular Access of Hemodialysis Patients
-
University Health Network, TorontoCompletedThe Study Focuses on the Effect of a New Supraglottic Airway With Built-in Cuff Pressure Indicator on Postoperative Pharyngolaryngeal Adverse EventsCanada
-
Cairo UniversityNot yet recruitingthe Main Focus of the Study is to Use Socket Sealing Abutment in Conditioning of the Soft Tissue After Immediate Implant Placement
-
Ingredion IncorporatedCompletedFocus of the Study is on Gut HealthUnited States
-
Heba A YassaEnrolling by invitationthe Study Focus on the Uses of Telephone and Other New Technology in Medicine, Diagnosis and TreatmentEgypt
-
St. Vincent's Medical CenterUnknownThis Study Has Been Designed to Compile Information on the Efficacy of the Partial Breast Intracavitary Brachytherapy in the Post Market Setting.United States
-
Ain Shams UniversityCompletedAdverse Effects in the Therapeutic Use of Other and Unspecified Agents Primarily Acting on the Respiratory System
-
Hallym University Kangnam Sacred Heart HospitalCompletedIn the Present Study, we Investigated the Effects of Oral Ambroxol on Tear Film and Ocular Surface.Korea, Republic of
-
University of Maryland, BaltimoreCompletedBasic Science Study of the Mechanisms of Attentional Enhancement by Compounds Acting on the Nicotinic ReceptorUnited States